Alternate Names: Lymphoma - non-Hodgkin's; Lymphocytic lymphoma; Histiocytic lymphoma; Lymphoblastic lymphoma; Cancer - non-Hodgkin's lymphoma
Causes and Risks:
The cancers vary from indolent disease to rapidly progressive cancer. The cause is unknown, but it may be associated with suppression of the immune system, especially after organ transplantation.
The tumors are graded according to their level of malignancy -- low grade, intermediate grade, or high grade. Burkitt’s tumor is an example of a high grade lymphoma. The tumors occur more frequently than Hodgkin’s lymphoma.
Most often it affects people over 50 years old. High-risk groups include organ transplant recipients and immunosuppressed people. The incidence is 3 out of 10,000 people.
Prevention: There is no known prevention.
Symptoms:
Additional symptom that may be associated with this disease:
Signs and Tests: Tests that may indicate non-Hodgkin’s lymphoma include:
A staging evaluation (tumor staging) to determine the extent of the disease includes: This disease may also alter the results of the following tests:
Treatment: Treatment depends upon the stage of the disease. Low-grade diseases may just need to be observed. When treatment becomes necessary, chemotherapy or radiation therapy may be used. Patients with more aggressive or resistant disease may require more intensive therapy. High-dose chemotherapy with bone marrow transplantation may be a treatment option in selected cases.
Support Groups: The stress of illness can often be helped by joining a support group where members share common experiences and problems. See cancer - support group.
Prognosis: The median survival is 6 to 8 years in low-grade lymphoma. Prognosis of high-grade lymphoma depends upon the response to chemotherapy or other treatment, with about 30% being cured.
Complications:
Call your health care provider if symptoms of this disorder develop.
If you have non-Hodgkin’s lymphoma, call your health care provider if you experience persistent fever or other signs of infection.